These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34643920)

  • 1. Genetic predisposition of SNPs in miRNA-149 (rs2292832) and FOXE1 (rs3758249) in thyroid Cancer.
    Khan R; Shaheen H; Mansoor Q; Abbasi SA; Fatima S; Ammar A; Baig RM
    Mol Biol Rep; 2021 Dec; 48(12):7801-7809. PubMed ID: 34643920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype Analyses in the Japanese and Belarusian Populations Reveal Independent Effects of rs965513 and rs1867277 but Do Not Support the Role of FOXE1 Polyalanine Tract Length in Conferring Risk for Papillary Thyroid Carcinoma.
    Nikitski AV; Rogounovitch TI; Bychkov A; Takahashi M; Yoshiura KI; Mitsutake N; Kawaguchi T; Matsuse M; Drozd VM; Demidchik Y; Nishihara E; Hirokawa M; Miyauchi A; Rubanovich AV; Matsuda F; Yamashita S; Saenko VA
    Thyroid; 2017 Feb; 27(2):224-235. PubMed ID: 27824288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis.
    Kang J; Deng XZ; Fan YB; Wu B
    Tumour Biol; 2014 Jul; 35(7):7085-96. PubMed ID: 24756757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population.
    Wei WJ; Lu ZW; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
    Int J Mol Sci; 2014 Nov; 15(11):20968-81. PubMed ID: 25405731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.
    Sigurdson AJ; Brenner AV; Roach JA; Goudeva L; Müller JA; Nerlich K; Reiners C; Schwab R; Pfeiffer L; Waldenberger M; Braganza M; Xu L; Sturgis EM; Yeager M; Chanock SJ; Pfeiffer RM; Abend M; Port M
    Carcinogenesis; 2016 Jul; 37(7):677-684. PubMed ID: 27207655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2.
    He H; Li W; Liyanarachchi S; Jendrzejewski J; Srinivas M; Davuluri RV; Nagy R; de la Chapelle A
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E164-72. PubMed ID: 25303483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The investigation of foxe1 variations in papillary thyroid carcinoma.
    Somuncu E; Karatas A; Ferahman S; Saygili N; Yilmaz E; Ozturk O; Kapan M
    Int J Clin Exp Pathol; 2015; 8(10):13458-64. PubMed ID: 26722557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.
    Bullock M; Duncan EL; O'Neill C; Tacon L; Sywak M; Sidhu S; Delbridge L; Learoyd D; Robinson BG; Ludgate M; Clifton-Bligh RJ
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1814-9. PubMed ID: 22736773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-524-5p suppresses the progression of papillary thyroid carcinoma cells via targeting on FOXE1 and ITGA3 in cell autophagy and cycling pathways.
    Liu H; Chen X; Lin T; Chen X; Yan J; Jiang S
    J Cell Physiol; 2019 Aug; 234(10):18382-18391. PubMed ID: 30941771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and Epigenetic Association of
    Achilla C; Chorti A; Papavramidis T; Angelis L; Chatzikyriakidou A
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between microRNA polymorphisms and cancer risk based on the findings of 66 case-control studies.
    Ma XP; Zhang T; Peng B; Yu L; Jiang de K
    PLoS One; 2013; 8(11):e79584. PubMed ID: 24278149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic Mutations of FOXE1 in Papillary Thyroid Cancer.
    Mond M; Bullock M; Yao Y; Clifton-Bligh RJ; Gilfillan C; Fuller PJ
    Thyroid; 2015 Aug; 25(8):904-10. PubMed ID: 25950909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
    He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
    Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.
    Kula D; Kalemba M; Puch Z; Polańska J; Świerniak M; Rusinek D; Żebracka-Gala J; Kowalska M; Handkiewicz-Junak D; Kowal M; Tyszkiewicz T; Piasna E; Czarniecka A; Pawlaczek A; Krajewska J; Szpak-Ulczok S; Jarząb B
    Endokrynol Pol; 2017; 68(3):283-289. PubMed ID: 28660995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.
    Landa I; Ruiz-Llorente S; Montero-Conde C; Inglada-Pérez L; Schiavi F; Leskelä S; Pita G; Milne R; Maravall J; Ramos I; Andía V; Rodríguez-Poyo P; Jara-Albarrán A; Meoro A; del Peso C; Arribas L; Iglesias P; Caballero J; Serrano J; Picó A; Pomares F; Giménez G; López-Mondéjar P; Castello R; Merante-Boschin I; Pelizzo MR; Mauricio D; Opocher G; Rodríguez-Antona C; González-Neira A; Matías-Guiu X; Santisteban P; Robledo M
    PLoS Genet; 2009 Sep; 5(9):e1000637. PubMed ID: 19730683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network-Based Analysis Reveals Association of FOXE1 Gene Polymorphisms in Thyroid Cancer Patients; A Case-Control Study in Southeast of Iran.
    Mehrazin A; Safarpour H; Davoudi ST; Parsamanesh N; Saeedi F; Miri-Moghaddam E
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2771-2776. PubMed ID: 32986379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXE1 association with differentiated thyroid cancer and its progression.
    Penna-Martinez M; Epp F; Kahles H; Ramos-Lopez E; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Holzer K; Bechstein WO; Zeuzem S; Vorländer C; Badenhoop K
    Thyroid; 2014 May; 24(5):845-51. PubMed ID: 24325646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic investigation of FOXE1 polyalanine tract in thyroid diseases: new insight on the role of FOXE1 in thyroid carcinoma.
    Kallel R; Belguith-Maalej S; Akdi A; Mnif M; Charfeddine I; Galofré P; Ghorbel A; Abid M; Marcos R; Ayadi H; Velázquez A; Hadj Kacem H
    Cancer Biomark; 2010-2011; 8(1):43-51. PubMed ID: 21896990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
    Dong G; Zhang R; Xu J; Guo Y
    Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
    Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.